Omega-3 Supplementation and Behavior Problems
1 other identifier
interventional
324
1 country
1
Brief Summary
The objectives of this project are as follows:
- 1.To assess whether omega-3 dietary supplementation for six months can reduce externalizing behavior problems (antisocial and aggressive behavior) in schoolchildren aged 8 to 18, both at the end of treatment and six months post-treatment
- 2.To assess whether omega-3 supplementation is more effective in children with more psychopathic-like traits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Feb 2015
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2014
CompletedFirst Posted
Study publicly available on registry
January 8, 2015
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedJuly 18, 2018
July 1, 2018
2.4 years
December 29, 2014
July 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Externalizing and internalizing behavior problems
The following instruments will be administered to both caregivers and the children to assess child behavior behavior problems (externalizing and internalizing) Adolescent self-reported measures include Reactive-Proactive Aggression Questionnaire (RPQ), Antisocial Personality Screening Device (APSD), Conduct and Oppositional Defiant Disorder Questionnaire (COD) and Child Behavior Checklist (CBCL - Attention and Anxiety/Depressed subscales only).
up to 12 months after initiation of trial: assessement at 0 months, 6 months (end of treatment) and 12 months (6 months post-tretament)
Secondary Outcomes (4)
Neurocognitive functioning
up to 12 months
Psychophysiological functioning
up to 12 months
Emotional empathy
up to 12 months
Grit
up to 12 months
Study Arms (3)
Omega-3 supplemented drink
EXPERIMENTALA 200 ml. drink product with 1.1 grams of omega-3 from Smartfish (Smartfish: Forsiden in Norway).
Placebo Drink
PLACEBO COMPARATORexactly the same fruit drink contained in the same packaging, but will contain no omega-3.
treatment-as-usual controls
NO INTERVENTIONNo drinks are taken.
Interventions
The drink has apple/ pear/ pomegranate taste which is well accepted by children and adolescents, is rich in natural antioxidants to help prevent oxidation of omega-3. The drink can be taken at any time during the day. 1/3 of the participants will be assigned to the omega-3 group after randomization. They are going to take the treatment for 6 months. They will be assessed at baseline, end of treatment and 6 months post-treatment.
Treatment duration is 6 months. They will be assessed at baseline (0 months), end of treatment (6 months) and 6 months post-treatment (12 months).
Eligibility Criteria
You may qualify if:
- children and adolescents between the age 8 and 18
You may not qualify if:
- unwilling to participate in a randomized, double-blind, placebo controlled trial,
- unable to give written, informed parental consent and assent from children,
- on medication that may modify lipid metabolism in the past 3 months
- significant use of omega-3 supplements in the past 6 months
- seafood allergies
- mental retardation
- epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Annis Funglead
- University of Pennsylvaniacollaborator
- The University of Hong Kongcollaborator
- Brooklyn College of the City University of New Yorkcollaborator
Study Sites (1)
City University of Hong Kong
Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annis Fung, Ph.D.
City University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- all participants and research assistants are blind to condition for the two fruit juice groups
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 29, 2014
First Posted
January 8, 2015
Study Start
February 1, 2015
Primary Completion
July 1, 2017
Study Completion
July 1, 2018
Last Updated
July 18, 2018
Record last verified: 2018-07